Dietary naringenin increases hepatic peroxisome proliferators–activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats
- 467 Downloads
Naringenin, a flavonoid present in grapefruit, has recently been shown to exert hypolipidemic and hypocholesterolemic effects, which has a particular importance for protecting against chronic diseases. However, the lipid-lowering potential of naringenin at the concentrations in the dietary range and its underlying mechanisms have yet to be fully elucidated.
The aim of the present study was (1) to investigate the effects of dietary naringenin on plasma and hepatic triglyceride and cholesterol levels and on adipose deposition in rat and (2) to determine the contribution of hepatic peroxisome proliferators–activated receptor α (PPARα) expression to fatty acid oxidation.
Male Long-Evans hooded rats were fed a diet supplemented with naringenin (0.003, 0.006, and 0.012%) for 6 weeks. We analyzed plasma and hepatic lipid contents and determined the protein expression of PPARα, carnitine-palmitoyl transferase 1L (CPT-1), and uncoupling protein 2 (UCP2), all of which are critical genes for fatty acid oxidation.
Naringenin supplementation caused a significant reduction in the amount of total triglyceride and cholesterol in plasma and liver. In addition, naringenin supplementation lowered adiposity and triglyceride contents in parametrial adipose tissue. Naringenin-fed animals showed a significant increase in PPARα protein expression in the liver. Furthermore, expression of CPT-1 and UCP2, both of which are known to be regulated by PPARα, was markedly enhanced by naringenin treatment.
Our results indicate that the activation of PPARα transcription factor and upregulation of its fatty acid oxidation target genes by dietary naringenin may contribute to the hypolipidemic and anti-adiposity effects in vivo.
KeywordsNaringenin Hypolipidemic effect Anti-adiposity PPAR-α CPT-1 UCP2 In vivo
This research was in part supported by Grants (S00000005000000) from the University of Massachusetts, Amherst.
- 3.Kurowska EM, Spence JD, Jordan J et al (2000) HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72:1095–1100Google Scholar
- 13.Wilcox LJ, Borradaile NM, de Dreu LE, Huff MW (2001) Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J Lipid Res 42:725–734Google Scholar
- 14.Allister EM, Borradaile NM, Edwards JY, Huff MW (2005) Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytes. Diabetes 54:1676–1683CrossRefGoogle Scholar
- 15.Kumpulainen J, Lehtonen M, Mattila P (1999) Trolox equivalent antioxidant capacity of average flavonoids intake in Finland. In: Kumpulainen JT, Salonen JT (ed) Natural antioxidants and anticarcinogens in nutrition, health and disease, Cambridge, pp 141–150Google Scholar
- 16.Vasilopoulou E, Georga K, Joergensen MB, Naska A, Trichopoulou A (2005) The antioxidant properties of greek foods and the flavonoid content of the mediterranean menu. Curr Med Chem 5:33–45Google Scholar
- 18.Staels B, Dallongeville J, Auwerx J, Schoonjans K et al (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98:2088–2093Google Scholar
- 23.Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470–475Google Scholar
- 24.Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509Google Scholar
- 25.Hsueh CT, Wu YC, Schwartz GK (2001) UCN-01 suppresses E2F–1 mediated by ubiquitin-proteasome-dependent degradation. Clin Cancer Res 7:669–674Google Scholar
- 26.Song J, Lu Y, Pang S, Chiu R (2004) An internal control for immunoblot analysis using the blotted membrane. Anal Biochem 331:201–203Google Scholar
- 27.Brady PS, Marine KA, Brady LJ, Ramsay RR (1989) Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs. Biochem J 260:93–100Google Scholar
- 30.Knekt P, Kumpulainen J, Jarvinen R, Rissanen H et al (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560–568Google Scholar
- 32.Wood N (2004) Hepatolipidemic effects of naringenin in high cornstarch-versus high coconut oil-fed rats. J Med Food 7:315–319Google Scholar
- 36.Kasim SE, LeBoeuf RC, Khilnani S, Tallapaka L et al (1992) Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. J Lipid Res 33:1–7Google Scholar
- 41.Keller J, Collet P, Bianchi A, Huin C et al (2000) Implications of peroxisome proliferator-activated receptors (PPARs) in development cell life status and disease. Int J Dev Biol 44:429–442Google Scholar
- 43.Kim S, Sohn I, Lee YS, Lee YS (2005) Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 135:33–41Google Scholar
- 45.Kannappan S, Anuradha CV (2009) Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome. Eur J Nutr. doi: 10.1007/s00394-009-0054-6
- 46.Kawada T, Takahashi N, Fushiki T (2001) Biochemical and physiological characteristics of fat cell. J Nutr Sci Vitaminol (Tokyo) 47:1–12Google Scholar